Carboplatin/Durvalumab/Pemetrexed Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of carboplatin, durvalumab, and pemetrexed that may be used in the treatment of non-small cell lung cancer (NSCLC).

**Synonyms:** - Carboplatin-Durvalumab-Pemetrexed - Carboplatin/Durvalumab/Pemetrexed - Carboplatin/Imfinzi/Alimta - Carboplatin/Pemetrexed Plus Durvalumab - Carboplatin/Pemetrexed/Durvalumab - Durvalumab Plus Carboplatin/Pemetrexed - Pemetrexed/Carboplatin Plus Durvalumab